Particulate β-glucan regulates the immunosuppression of granulocytic myeloid-derived suppressor cells by inhibiting NFIA expression

References

• Watanabe S, Deguchi K, Zheng R, Tamai H, Wang LX, Cohen PA, Shu S. Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes. J Immunol, 2008; 181(5): 3291-3300; PMID:18714001; http://dx.doi.org/10.4049/jimmunol.181.5.3291
   PubMed Web of Science ®Google Scholar
• Lee JM, Kim EK, Seo H, Jeon I, Chae MJ, Park YJ, Song B, Kim YS, Kim YJ, Ko HJ et al. Serum amyloid A3 exacerbates cancer by enhancing the suppressive capacity of myeloid-derived suppressor cells via TLR2-dependent STAT3 activation. Eur J Immunol, 2014; 44(6):1672-1684; PMID:24659444; http://dx.doi.org/10.1002/eji.201343867
   PubMed Web of Science ®Google Scholar
• Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol, 2009; 182(8):449-4506; PMID:19342621; http://dx.doi.org/10.4049/jimmunol.0802740
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol, 2009; 9(3):162-174; PMID:19197294; http://dx.doi.org/10.1038/nri2506
   PubMed Web of Science ®Google Scholar
• Li L, Zhang J, Diao W, Wang D, Wei Y, Zhang CY, Zen K. MicroRNA-155 and MicroRNA-21 promote the expansion of functional myeloid-derived suppressor cells. J Immunol, 2014; 192(3):1034-1043; PMID:24391219; http://dx.doi.org/10.4049/jimmunol.1301309
   PubMed Web of Science ®Google Scholar
• Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C, Beschin A, De Baetselier P, Van Ginderachter JA. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood, 2008; 111(8):4233-4244; PMID:18272812; http://dx.doi.org/10.1182/blood-2007-07-099226
   PubMed Web of Science ®Google Scholar
• Youn JI, Collazo M, Shalova IN, Biswas SK, Gabrilovich DI. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J Leukoc Biol, 2012; 91(1):167-181; PMID:21954284; http://dx.doi.org/10.1189/jlb.0311177
   PubMed Web of Science ®Google Scholar
• Ko JS, Zea AH, Rini BI, Ireland JL, Elson P, Cohen P, Golshayan A, Rayman PA, Wood L, Garcia J et al. Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients. Clin Cancer Res, 2009; 15(6):2148-2157; PMID:19276286; http://dx.doi.org/10.1158/1078-0432.CCR-08-1332
   PubMed Web of Science ®Google Scholar
• Qi C, Cai Y, Gunn L, Ding C, Li B, Kloecker G, Qian K, Vasilakos J, Saijo S, Iwakura Y et al. Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans. Blood, 2011; 117(25):6825-6836; PMID:21531981; http://dx.doi.org/10.1182/blood-2011-02-339812
   PubMed Web of Science ®Google Scholar
• Chihara G, Hamuro J, Maeda Y, Arai Y, Fukuoka F. Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from Lentinus edodes (Berk.) Sing. (an edible mushroom). Cancer Res, 1970; 30(11):2776-2781; PMID:5530561.
   PubMed Web of Science ®Google Scholar
• McIntosh M, Stone BA, Stanisich VA. Curdlan and other bacterial (1->3)-β-D-glucans. Appl Microbiol Biotechnol 2005; 68(2):163-173; PMID:15818477; http://dx.doi.org/10.1007/s00253-005-1959-5
   PubMed Web of Science ®Google Scholar
• Barreto-Bergter E, Figueiredo RT. Fungal glycans and the innate immune recognition. Front Cell Infect Microbiol 2014; 4: 145; PMID:25353009; http://dx.doi.org/10.3389/fcimb.2014.00145
   PubMed Web of Science ®Google Scholar
• Lowman DW, Greene RR, Bearden DW, Kruppa MD, Pottier M, Monteiro MA, Soldatov DV, Ensley HE, Cheng SC, Netea MG et al. Novel structural features in Candida albicans hyphal glucan provide a basis for differential innate immune recognition of hyphae versus yeast. J Biol Chem, 2014; 289(6):3432-3443; PMID:24344127; http://dx.doi.org/10.1074/jbc.M113.529131
   PubMed Web of Science ®Google Scholar
• Schwartz B, Hadar Y. Possible mechanisms of action of mushroom-derived glucans on inflammatory bowel disease and associated cancer. Ann Transl Med, 2014; 2(2):19; PMID:25332995; http://dx.doi.org/10.3978/j.issn.2305-5839.2014.01.03
   PubMedGoogle Scholar
• Brown GD, Gordon S. Immune recognition. A new receptor for β-glucans. Nature, 2001; 413(6851):36-37; PMID:11544516; http://dx.doi.org/10.1038/35092620
   PubMed Web of Science ®Google Scholar
• Harnack U, Eckert K, Fichtner I, Pecher G. Oral administration of a soluble 1-3, 1-6 β-glucan during prophylactic survivin peptide vaccination diminishes growth of a B cell lymphoma in mice. Int Immunopharmacol, 2009; 9(11):1298-1303; PMID:19664725; http://dx.doi.org/10.1016/j.intimp.2009.07.013
   PubMed Web of Science ®Google Scholar
• Chen Y, Dong L, Weng D, Liu F, Song L, Li C, Tang W, Chen J. 1,3-β-glucan affects the balance of Th1/Th2 cytokines by promoting secretion of anti-inflammatory cytokines in vitro. Mol Med Rep, 2013; 8(2):708-712; PMID:23799616; http://dx.doi.org/10.3892/mmr.2013.1553
   PubMed Web of Science ®Google Scholar
• Li B, Cai Y, Qi C, Hansen R, Ding C, Mitchell TC, Yan J. Orally administered particulate β-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancer. Clin Cancer Res, 2010; 16(21):5153-5164; PMID:20855461; http://dx.doi.org/10.1158/1078-0432.CCR-10-0820
   PubMed Web of Science ®Google Scholar
• Tian J, Ma J, Ma K, Guo H, Baidoo SE, Zhang Y, Yan J, Lu L, Xu H, Wang S. β-Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells. Eur J Immunol, 2013; 43(5):1220-1230; PMID:23424024; http://dx.doi.org/10.1002/eji.201242841
   PubMed Web of Science ®Google Scholar
• Gronostajski RM. Roles of the NFI/CTF gene family in transcription and development. Gene, 2000; 249(1-2):31-45; PMID:10831836; http://dx.doi.org/10.1016/S0378-1119(00)00140-2
   PubMed Web of Science ®Google Scholar
• Starnes LM, Sorrentino A, Pelosi E, Ballarino M, Morsilli O, Biffoni M, Santoro S, Felli N, Castelli G, De Marchis ML. NFI-A directs the fate of hematopoietic progenitors to the erythroid or granulocytic lineage and controls β-globin and G-CSF receptor expression. Blood, 2009; 114(9):1753-1763; PMID:19542302; http://dx.doi.org/10.1182/blood-2008-12-196196
   PubMed Web of Science ®Google Scholar
• Glasgow SM, Laug D, Brawley VS, Zhang Z, Corder A, Yin Z, Wong ST, Li XN, Foster AE, Ahmed N. The miR-223/nuclear factor I-A axis regulates glial precursor proliferation and tumorigenesis in the CNS. J Neurosci, 2013; 33(33):13560-13568; PMID:23946414; http://dx.doi.org/10.1523/JNEUROSCI.0321-13.2013
   PubMed Web of Science ®Google Scholar
• Talmadge JE, Hood KC, Zobel LC, Shafer LR, Coles M, Toth B. Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion. Int Immunopharmacol, 2007; 7(2):140-151; PMID:17178380; http://dx.doi.org/10.1016/j.intimp.2006.09.021
   PubMed Web of Science ®Google Scholar
• Serafini P, Meckel K, Kelso M, Noonan K, Califano J, Koch W, Dolcetti L, Bronte V, Borrello I. Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function. J Exp Med, 2006; 203(12):2691-2702; PMID:17101732; http://dx.doi.org/10.1084/jem.20061104
   PubMed Web of Science ®Google Scholar
• Goodridge HS, Wolf AJ, Underhill DM. Beta-glucan recognition by the innate immune system. Immunol Rev, 2009; 230(1):38-50; PMID:19594628; http://dx.doi.org/10.1111/j.1600-065X.2009.00793.x
   PubMed Web of Science ®Google Scholar
• Leentjens J, Quintin J, Gerretsen J, Kox M, Pickkers P, Netea MG. The effects of orally administered Beta-glucan on innate immune responses in humans, a randomized open-label intervention pilot-study. PLoS One, 2014; 9(9):e108794; PMID:25268806; http://dx.doi.org/10.1371/journal.pone.0108794
   PubMed Web of Science ®Google Scholar
• Karumuthil-Melethil S, Gudi R, Johnson BM, Perez N, Vasu C. Fungal β-glucan, a Dectin-1 ligand, promotes protection from type 1 diabetes by inducing regulatory innate immune response. J Immunol, 2014; 193(7):3308-3321; PMID:25143443; http://dx.doi.org/10.4049/jimmunol.1400186
   PubMed Web of Science ®Google Scholar
• Lavi I, Nimri L, Levinson D, Peri I, Hadar Y, Schwartz B. Glucans from the edible mushroom Pleurotus pulmonarius inhibit colitis-associated colon carcinogenesis in mice. J Gastroenterol, 2012; 47(5):504-518; PMID:22187166; http://dx.doi.org/10.1007/s00535-011-0514-7
   PubMed Web of Science ®Google Scholar
• Nosal'ova V, Bobek P, Cerna S, Galbavý S, Stvrtina S. Effects of pleuran (β-glucan isolated from Pleurotus ostreatus) on experimental colitis in rats. Physiol Res, 2001; 50(6):575-581; PMID:11829318.
   PubMed Web of Science ®Google Scholar
• Liu J, Gunn L, Hansen R, Yan J. Combined yeast-derived β-glucan with anti-tumor monoclonal antibody for cancer immunotherapy. Exp Mol Pathol, 2009; 86(3):208-214; PMID:19454271; http://dx.doi.org/10.1016/j.yexmp.2009.01.006
   PubMed Web of Science ®Google Scholar
• Leibundgut-Landmann S, Osorio F, Brown GD, Reis e Sousa C. Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses. Blood, 2008; 112(13):4971-4980; PMID:18818389; http://dx.doi.org/10.1182/blood-2008-05-158469
   PubMed Web of Science ®Google Scholar
• Galan-Diez M, Arana DM, Serrano-Gomez D, Kremer L, Casasnovas JM, Ortega M, Cuesta-Domínguez A, Corbí AL, Pla J, Fernández-Ruiz E. Candida albicans β-glucan exposure is controlled by the fungal CEK1-mediated mitogen-activated protein kinase pathway that modulates immune responses triggered through dectin-1. Infect Immun, 2010; 78(4):1426-1436; PMID:20100861; http://dx.doi.org/10.1128/IAI.00989-09
   PubMed Web of Science ®Google Scholar
• Waki H, Nakamura M, Yamauchi T, Wakabayashi K, Yu J, Hirose-Yotsuya L, Take K, Sun W, Iwabu M, Okada-Iwabu M. Global mapping of cell type-specific open chromatin by FAIRE-seq reveals the regulatory role of the NFI family in adipocyte differentiation. PLoS Genet, 2011; 7(10):e1002311; PMID:22028663; http://dx.doi.org/10.1371/journal.pgen.1002311
   PubMedGoogle Scholar
• Alevizopoulos A, Mermod N. Antagonistic regulation of a proline-rich transcription factor by transforming growth factor β and tumor necrosis factor alpha. J Biol Chem, 1996; 271(47):29672-29681; PMID:8939900; http://dx.doi.org/10.1074/jbc.271.47.29672
   PubMed Web of Science ®Google Scholar
• Hou J, Zhou Y, Zheng Y, Fan J, Zhou W, Ng IO, Sun H, Qin L, Qiu S, Lee JM et al. Hepatic RIG-I predicts survival and interferon- α therapeutic response in hepatocellular carcinoma. Cancer Cell, 2014; 25(1):49-63; PMID:24360797; http://dx.doi.org/10.1016/j.ccr.2013.11.011
   PubMed Web of Science ®Google Scholar